Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Weather
7 NC counties are under alert, including Johnston County.
Program
On WRAL at 6: Hidden fees in your childâs school lunch payment ð¨ð¸ 5 On Your Side shows you how to keep more money in your pocket
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Intellia Thera CS
(NQ:
NTLA
)
23.60
+0.42 (+1.81%)
Streaming Delayed Price
Updated: 10:06 AM EDT, Aug 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Intellia Thera CS
< Previous
1
2
...
8
9
10
11
12
13
14
15
Next >
The Daily Biotech Pulse: FDA Nod For Lilly, Regulus Slumps On Study Discontinuation, ObSeva Strikes Linzagolix Commercialization Deal
October 13, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Revance Clarifies Gabellar Line Treatment Review On Track Responding to the...
Via
Benzinga
Exposures
Product Safety
Intellia Therapeutics & UiPath Elliott Wave Analysis
October 09, 2021
US Stocks NTLA &PATH technical analysis, Elliott Wave forecast & trading.
Via
Talk Markets
12 Health Care Stocks Moving In Friday's Intraday Session
October 08, 2021
Gainers ChemoCentryx (NASDAQ:CCXI) stock increased by 70.43% to $33.41 during Friday's regular session. As of 12:30 EST, this security is trading at a volume of 74.6...
Via
Benzinga
Intellia To Test Second CRISPR Therapeutic In Hereditary Angioedema Patients
October 06, 2021
The New Zealand Medicines and Medical Devices Safety Authority (MEDSAFE) has signed off Intellia Therapeutics Inc's (NASDAQ: NTLA) Phase 1/2 study of NTLA-2002...
Via
Benzinga
Stock Trading: Intellia Therapeutics Inc & Zillow Technical Analysis
October 02, 2021
Intellia and Zillow technical analysis, Elliott Wave forecast.
Via
Talk Markets
Where Intellia Therapeutics Stands With Analysts
September 24, 2021
Within the last quarter, Intellia Therapeutics (NASDAQ:NTLA) has observed t...
Via
Benzinga
Technical Analysis : Pinduoduo (PINS) & Intellia Therapeutics (NTLA)
September 01, 2021
Here's a technical analysis of two stocks: Pinduoduo (PDD) & Intellia Therapeutics.
Via
Talk Markets
CareDx & Intellia Therapeutics Elliott Wave Analysis
August 25, 2021
At this point the flat correction into wave (4) could be completed, if not we are just missing one last leg down.
Via
Talk Markets
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
October 08, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 7) Alkermes plc (NASDAQ: ALKS)...
Via
Benzinga
Exposures
Product Safety
Where Intellia Therapeutics Stands With Analysts
August 06, 2021
Intellia Therapeutics (NASDAQ:NTLA) has observed the following analyst rati...
Via
Benzinga
Why Intellia Therapeutics' Stock Is Trading Higher Today
August 05, 2021
Intellia Therapeutics Inc (NASDAQ:NTLA) is trading si...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 5, 2021
October 05, 2021
Upgrades Wolfe Research upgraded the previous rating for PACCAR Inc (NASDAQ:
Via
Benzinga
Intellia To Test CRISPR-Engineered TCR-T Cell Candidate In Acute Myeloid Leukemia Patients
September 16, 2021
The FDA has signed off Intellia Therapeutics Inc's (NASDAQ: NTLA) investigational new drug (IND) application for NTLA-5001. Related Content: Intellia...
Via
Benzinga
Exposures
Product Safety
Why Intellia Therapeutics Shares Are Trading Higher Today
August 05, 2021
...
Via
Benzinga
Unusual Options Activity Insight: Intellia Therapeutics
July 30, 2021
On Friday, shares of Intellia Therapeutics (NASDAQ:NTLA) ...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 24, 2021
September 24, 2021
Upgrades Berenberg upgraded the previous rating for Tenable Holdings Inc (NASDAQ:
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
September 16, 2021
Gainers Leap Therapeutics (NASDAQ:LPTX) stock rose 32.64% to $2.56 during Thursday's pre-market session. The company's market cap stands at $152.7 million. Phio...
Via
Benzinga
Forget About the Genomic Revolution, the Proteomic Revolution Is Coming
September 03, 2021
Thanks to one small protein sequencing startup, we're entering a new era of proteomics via NGPS technologies that will enable massively parallel protein sequencing.
Via
InvestorPlace
Gene Editing Stocks: The Trial News Lifting NTLA, CRSP and EDIT Stocks Today
August 23, 2021
Today, gene editing stocks are getting a big boost after an intriguing data release by Editas for the company's new SLEEK technology.
Via
InvestorPlace
US Stocks: AME, AVAV, NIO, NTLA, PDD & SNAP Technical Analysis
August 09, 2021
Technical stocks analysis: Ametek, AeroVironment, Nio Inc, Intellia Therapeutics, Pinduoduo, and Snap.
Via
Talk Markets
Intellia Therapeutics, inc (NTLA) Q2 2021 Earnings Call Transcript
August 06, 2021
NTLA earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
10 Biggest Price Target Changes For Friday
August 06, 2021
Piper Sandler boosted the price target for Moderna, Inc. (NASDAQ: MRNA) from $246 to $445. Moderna shares fell 1.6% to $409.55 in pre-market trading. Needham cut the price...
Via
Benzinga
99 Biggest Movers From Yesterday
August 06, 2021
Gainers Score Media and Gaming Inc. (NASDAQ: SCR) shares climbed 79.9% to close at $32.64 on Thursday after the company, and Penn National Gaming, announced they entered into a...
Via
Benzinga
Why Shares of Intellia Therapeutics Are Jumping Today
August 05, 2021
More progress in the pipeline has investors bullish on the company's shares.
Via
The Motley Fool
Gene Editing Stocks: Why EDIT, NTLA, CRSP Stocks Are Climbing Today
August 05, 2021
Today, investors in gene editing stocks are seeing a lot of green as earnings were announced along with business updates from key players.
Via
InvestorPlace
3 Reasons Caribou Biosciences Could Be the Best Gene-Editing Stock for Your Portfolio
July 27, 2021
The company has a pedigree and a novel approach that could put it at the top of the CRISPR heap.
Via
The Motley Fool
Why CRISPR Therapeutics, Editas Medicine, and Beam Therapeutics Dropped This Week
July 16, 2021
After rallying on the coattails of Intelllia's breakthrough, these companies have given back their June gains.
Via
The Motley Fool
After Game-Changing Clinical Trial Results, These 2 Cathie Wood Stocks Are Exploding
July 15, 2021
It's a good time to be a gene-editing company.
Via
The Motley Fool
The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings
August 04, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 3) Absci, CORP (NASDAQ: ABSI) (...
Via
Benzinga
The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs
August 01, 2021
Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results....
Via
Benzinga
Exposures
Product Safety
< Previous
1
2
...
8
9
10
11
12
13
14
15
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.